2019
DOI: 10.1007/s00408-019-00305-5
|View full text |Cite
|
Sign up to set email alerts
|

The Powerful Placebo Effect in Cough: Relevance to Treatment and Clinical Trials

Abstract: Interest in the placebo effect of medicines has developed from the use of placebo treatments as controls in clinical trials into a whole new area of research around how placebos fit into a psychosocial model of therapeutics. The large placebo effect associated with cough medicines is both a problem and an opportunity for researchers: a problem for clinical trials on new actives as the active must beat the large placebo effect, and an opportunity for harnessing the placebo effect to produce effective cough medi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
41
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 53 publications
(48 citation statements)
references
References 52 publications
7
41
0
Order By: Relevance
“…It will be important to consider if in the future these medicines are used to treat acute cough if they will be administered to patients as tablets or if pharmaceutical companies will harness the power of excipients to enhance the efficacy of these new medicines. If new cough medicines are to be marketed as syrups rather than tablets, then this may complicate clinical trials on these new medicines, as the placebo effect and other actions of excipients may be the major component of the efficacy of the new cough product [1,26]. The easiest way forward is to conduct the clinical trials on tablet formulations and to conduct consumer market research on how patients will react to a new cough medicine in tablet form.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It will be important to consider if in the future these medicines are used to treat acute cough if they will be administered to patients as tablets or if pharmaceutical companies will harness the power of excipients to enhance the efficacy of these new medicines. If new cough medicines are to be marketed as syrups rather than tablets, then this may complicate clinical trials on these new medicines, as the placebo effect and other actions of excipients may be the major component of the efficacy of the new cough product [1,26]. The easiest way forward is to conduct the clinical trials on tablet formulations and to conduct consumer market research on how patients will react to a new cough medicine in tablet form.…”
Section: Discussionmentioning
confidence: 99%
“…The color of tablets has been shown to influence the perception of their properties as sedatives or stimulants with red yellow and orange associated with stimulant effects, and blue and green colors with tranquilizing effects [25]. The color of a cough medicine may influence perception about its efficacy and enhance its placebo effect, although no published research has been found on the effect of color on the placebo effect of cough medicines [26].…”
Section: Colorsmentioning
confidence: 99%
“…4, July 2020 servational studies [71,72]. Cough is frequently self-limiting and prone to placebo effects [73], which may underlie the large discrepancy between placebo-controlled and uncontrolled (observational) studies.…”
Section: New Concepts To Consider In the Evaluation And Management Ofmentioning
confidence: 99%
“…However, placebo-controlled studies indicate that true therapeutic benefits gained from treating these conditions may be much less than the findings suggested from observational studies [ 71 , 72 ]. Cough is frequently self-limiting and prone to placebo effects [ 73 ], which may underlie the large discrepancy between placebo-controlled and uncontrolled (observational) studies.…”
Section: New Concepts To Consider In the Evaluation And Management Ofmentioning
confidence: 99%
“…Thankfully, the last decade has seen a great increase in cough-related research which has led to multiple antitussive drug development programs currently underway [ 9 ]. Cough-related articles featured in 2020 included State-of-the-Art reviews on the placebo effect in cough clinical trials [ 2 ], the role of excipients in antitussive preparations [ 11 ], and an update on the status of chronic cough in China [ 3 ]. Other topics covered were drug-associated cough [ 82 ], therapeutic strategies for chronic cough [ 79 , 83 ], the role of cough assessment in monitoring patients with asthma [ 36 ] and COPD [ 47 ], the question of whether there will be an emergence of a post-COVID-19 chronic cough [ 23 ], and abstracts from the Seventh American Cough Conference [ 84 ].…”
mentioning
confidence: 99%